Background illustration for clinical trials search

Small Cell Lung Cancer Clinical Trials

Browse 642 small cell lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

for
Solid Tumor, Adult, Triple Negative Breast Cancer,
Location: Scottsdale AZ, La Jolla CA, Stanford CA
Sponsor: BioEclipse Therapeutics

Sex: All

Age: 18+

Code: NCT04282044

Phase1, Recruiting

Synapse 3D With Intravascular Indocyanine Green

for
Non-small Cell Lung Cancer, Primary Neoplasm
Location: Hamilton
Sponsor: St. Joseph's Healthcare Hamilton

Sex: All

Age: 18+

Code: NCT03953144

Phase1, Phase2, Recruiting

A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT02927340

Phase2, Recruiting

Using Urine Samples to Identify Lung Cancer

for
Non Small Cell Lung Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06033248

Recruiting

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

for
Non-small Cell Lung Cancer
Location: Syracuse NY
Sponsor: State University of New York - Upstate Medical University

Sex: All

Age: 18+

Code: NCT02619448

Early_phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Southfield MI
Sponsor: St. John Providence Health System

Sex: All

Age: 18+

Code: NCT00150657

Phase2, Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

for
Muscle-Invasive Bladder Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06529822

Phase1, Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase1, Phase2, Recruiting

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

for
Gastrointestinal Stromal Tumors, Small-cell Lung Cancer,
Location: Cleveland OH, Ann Arbor MI, Houston TX, Portland OR
Sponsor: Novelty Nobility, Inc.

Sex: All

Age: 18+

Code: NCT06805825

Phase1, Recruiting

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

for
Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer
Location: Boston MA, Canton OH, Detroit MI
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.

Sex: All

Age: 18+

Code: NCT03797391

Phase1, Phase2, Recruiting

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

for
Non-small Cell Lung Cancer
Location: The Bronx NY, Salisbury MD, Baltimore MD, Pinehurst NC,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06745882

Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for
Unresectable Melanoma, Metastatic Melanoma,
Location: New York NY, Miami FL, Pittsburgh PA, Orlando FL,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase1, Phase2, Recruiting

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

for
Advanced Non Small Cell Lung Cancer
Location: Iowa City IA
Sponsor: CellSight Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06107374

Phase2, Recruiting

Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: New York NY
Sponsor: Sun Farm Corporation

Sex: All

Age: 18+

Code: NCT00246727

Phase3, Recruiting

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

for
Lung Cancer, Lung Cancer Metastatic, Brain Metastases,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05419076

Phase2, Recruiting

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

for
Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer,
Location: Baltimore MD
Sponsor: A&G Pharmaceutical Inc.

Sex: All

Age: 18+

Code: NCT05627960

Phase1, Recruiting

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

for
Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Tampa FL
Sponsor: Memgen, Inc.

Sex: All

Age: 18+

Code: NCT05076760

Phase1, Recruiting

Repositioning Immunotherapy in VetArans With Lung Cancer

for
Non-Small Cell Lung Cancer
Location: West Haven CT, Washington D.C. DC, Richmond VA,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06275360

Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Metastatic Non-small Cell Lung Cancer
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06417814

Phase3, Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

for
Large Cell Neuroendocrine Carcinoma,
Location: Princeton NJ, Glen Burnie MD, Tampa FL, Cleveland OH,
Sponsor: Molecular Partners AG

Sex: All

Age: 18+

Code: NCT07278479

Phase1, Phase2, Recruiting